We contribute to people's health and comfortable life through our reliable quality and advanced testing technologies.
Since our service started in 1977, we have responded to requests from private companies in the pharmaceutical, food, and other industries, as well as government agencies and academia in a variety of fields, including pharmaceuticals, regenerative medicine, medical devices, agricultural chemicals, chemical substances, and cosmetics, as a partner in R&D. We provide a high level of service through our advanced technology and knowledge, and the comprehensive capabilities we have developed through many years of experience. We provide high-level services based on our advanced technologies, knowledge, and comprehensive capabilities cultivated through many years of experience. We provide a wide range of services from various safety studies, pharmacodynamic studies, and pharmacokinetic studies for regulatory approval applications to exploratory studies in the early stages of research and development at facilities compliant with GLP for pharmaceuticals, GLP for medical devices, GLP for regenerative medical products, GLP for agricultural chemicals, GLP for the Chemical Substances Control Law, etc.
We provide total support from basic research (planning) to a diverse menu of studies covering toxicity, pharmacology, and pharmacokinetics, as well as transition to the clinical phase and regulatory compliance. We also provide flexible support for project management, exploratory screening, and new modality evaluation.
In addition to JSTP and JCVP certified pathologists, we have experienced professionals such as veterinarians, pharmacists, laboratory animal technicians, and JSOT certified toxicologists, etc. We can provide tailor-made services for the evaluation of new modalities and new products, including the start-up of new evaluation systems.
We have obtained full accreditation from AAALAC International, an international nonprofit organization that evaluates test facilities for humane management of animals, through our efforts to comply with relevant laws and regulations on laboratory animal welfare, to provide education and training for personnel handling test animals, and to enhance environmental enrichment.
Mediford offers a variety of contract services from establishment and banking of PDX-derived cell lines to conducting pharmacological studies at the GLP-certified facilities of Kumamoto Laboratories. The PDX models are more predictive of clinical outcomes than conventional "cancer cell lines" and will be useful for your research and development purposes.
Mediford provides various contract services using clinical isolates (PDC: Patient-Derived Cell) established at the National Cancer Center.
We provide a wide range of services in the development of regenerative medical products from consulting to medical writing for diseases that are difficult to treat with conventional methods. We support each stage of the development process up to submission of application for approval by providing contract services that meet a wide variety of research needs, including toxicity studies (GLP), efficacy and biodistribution studies (reliability standards), and medical writing at research facilities fully accredited by AAALAC.